Notably, neurodegeneration in AstTau is associated with a loss of excitatory neurons as evidenced by scRNA-seq cell-type composition analysis and 25% loss of VGLUT1 immunolabeling, as is observed in clinical tauopathy progression (Supplementary Fig. 10d–f). Here, SLC17A7 is linked to tauopathy.